Australia Trials ‘More Transparent’ PBS Listing Procedure
The Move Involves Changes To Public Summary Document Process
Stakeholders have been asked to test-run a new approach to preparing Public Summary Documents for medicines submitted for reimbursement in Australia.
You may also be interested in...
Pharmaceutical companies in Australia can look forward to more streamlined processes for the submission and evaluation of new drugs for listing on the Pharmaceutical Benefits Scheme from July.
Despite the life sciences industry’s call for continued alignment of medicines regulation with the EU from next year and for some sort of co-operation with the European Medicines Agency, it seems the UK government is prepared to make only small concessions.
The UK’s decision to pull out of Europe’s Unified Patent Court system throws the future of the whole project into doubt.